The following table provides information about the project.
EDEX - EDUCATIONAL EXCELLENCE CORPORATION LIMITED
|Coordinator Country||Cyprus [CY]|
|Total cost||4˙984˙033 €|
|EC max contribution||4˙984˙033 € (100%)|
1. H2020-EU.3.1.5. (Methods and data)
|Duration (year-month-day)||from 2017-11-01 to 2020-10-31|
Take a look of project's partnership.
|1||EDEX - EDUCATIONAL EXCELLENCE CORPORATION LIMITED||CY (NICOSIA)||coordinator||521˙000.00|
|2||ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS||EL (THERMI THESSALONIKI)||participant||506˙875.00|
|3||CENTER FOR TECHNOLOGY RESEARCH AND INNOVATION (CETRI) LTD||CY (LIMASSOL)||participant||477˙000.00|
|4||SMARTEX S.R.L.||IT (PRATO)||participant||456˙062.00|
|5||LIVERPOOL JOHN MOORES UNIVERSITY||UK (LIVERPOOL)||participant||444˙721.00|
|6||PANEPISTIMIO PATRON||EL (RIO PATRAS)||participant||431˙250.00|
|7||ACONDICIONAMIENTO TARRASENSE ASSOCIACION||ES (TERRASSA)||participant||422˙500.00|
|8||FONDAZIONE RI.MED||IT (PALERMO)||participant||399˙062.00|
|9||KATHOLIEKE UNIVERSITEIT LEUVEN||BE (LEUVEN)||participant||354˙062.00|
|10||FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA||ES (VALENCIA)||participant||317˙250.00|
|11||AXIA INNOVATION UG||DE (MUNCHEN)||participant||248˙750.00|
|12||ANIMUS KENTRO APOTHERAPEIAS KAI APOKATASTASIS ANONYMI ETAIRIA||EL (LARISSA)||participant||218˙750.00|
Osteoarthritis (OA) is a degenerative disease of the articular cartilage and the most common form of arthritis that causes joint pain, mobility limitation and, thus, reduces independence and overall quality of life. Although the usual population associated with the condition is the elderly (65 years old ranges from 12- 30%), who are mostly inactive, athletes and younger individuals are also susceptible. Whilst the available data have implicated the role of the various modifiable or non-modifiable risk factors in the development and progression of OA, no study has conclusively explored the interaction and integration of other information sets in a patient-specific manner. The current OACTIVE project intents to make a significant leap forward adopting a multi-scale holistic approach where patient-specific information from various levels, including cell, tissue, organ and whole body will be integrated and combined with information from other sources such as biochemical/inflammatory biomarkers, behaviour modeling and social/environmental risk factors to generate robust predictors for new personalised interventions for delaying onset and slowing down progression of OA. OACTIVE targets to patient-specific OA prediction and interventions by using a combination of mechanistic, phenomenological computational models, simulations and big data analytics. Once constructed, these models will be used to simulate and predict optimal treatments, better diagnostics, and improved patient outcomes. Overcoming the limitation of the current treatment interventions, Augmented Reality empowered interventions will be developed in a personalised framework allowing patients experience the treatment as more enjoyable, resulting in greater motivation, engagement, and training adherence. OACTIVE’s mission is to improve healthcare by transforming and accelerating the OA diagnosis and prediction based on a more comprehensive understanding of disease pathophysiology, dynamics, and patient outcomes.
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OACTIVE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OACTIVE" are provided by the European Opendata Portal: CORDIS opendata.